spacer
home > ict > summer 2018 > gaining from gamification
PUBLICATIONS
International Clinical Trials

Gaining from Gamification

Much of the data in clinical research to capture the patient voice in clinical trials, observational research, and clinical practice is gathered using questionnaires. However, conventional questionnaire design and, notably, online surveys can be conceived as dull and unengaging, resulting in negative respondent behaviour such as speeding, random responding, lack of attention, and premature termination, ultimately leading to lower quality data (1).

Writing good survey questions may seem deceptively simple. However, the challenges facing questionnaire developers include:
• Getting respondents’ attention
• Getting respondents to read things
• Getting respondents to think
• Getting people to respond

Maintaining the respondent’s engagement is a key factor in ensuring the data quality does not suffer and that a surprisingly long questionnaire can be administered without significant deterioration in the quality of the data, particularly if efforts are made to maintain respondent motivation (2).

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
Dr Keith Meadows holds a PhD in psychology from the University of London, UK, and has held academic posts at a number of universities conducting health and market research across Europe. He has a range of experience including development and evaluation of clinical outcome assessment measures, qualitative research, and survey design. Keith founded Health Outcomes Solutions (formally DHP Research & Consultancy) to help healthcare agencies and pharmaceutical companies across a range of conditions get targeted answers to patient behaviour, experience, and outcomes using both traditional and innovative approaches.
spacer
Dr Keith Meadows
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

Evolution Summit Press Release

“Many clinical trials today face delays because of difficulties in recruiting the required number of patients within the timeline. Sponsors need to look at other regions outside the US and Western Europe, that have access to a large pool of motivated patients, without compromising quality or anything else,” says Roman Hrynchuk, Chief Operating Officer, SanaClis. SanaClis was a solution provider at the Marcus Evans Evolution Summit March 2020.
More info >>

White Papers

Clinical Trials in Emerging Markets: Goldmines or Landmines?

Pharm-Olam, LLC

Over the past decade, biopharmaceutical companies have increasingly turned to emerging markets as a way to reduce clinical trial costs and timelines. Areas such as Eastern Europe, India, and Latin America—with their ready population of treatment naïve patients—can be an answer to the intense competition for patients seen in developed markets. Many of the countries within these regions may now be considered as “emerged” countries but yet, conducting trials in these regions does require some special attention and expertise. Before deciding to conduct studies in these areas, companies should have a full appreciation for the ethical, medical, regulatory, legal, and operational hurdles that must be surmounted for success. Here we highlight a number of those issues and offer our recommendations for how sponsor companies can deal with them effectively.
More info >>

 
Industry Events

World Vaccine Congress Europe

18-21 October 2020, Barcelona, Spain

The World Vaccine Congress is an award-winning series of conferences and exhibitions that have grown to become the largest and most established vaccine meeting of its kind across the globe. Our credibility is show through the prestigious scientific advisory board that spend months of hard work creating a new and topical agenda, year on year.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement